MoS2 Bandgap: Key Insights for Bioscience and Health

Molybdenum disulfide, known as MoS₂, has a bandgap that shifts from indirect to direct when the material is thinned to a single atomic layer, and that shift is the reason it has become one of the most studied nanomaterials in bioscience and health research. The bandgap controls how the material absorbs and emits light, responds to electrical signals, and generates reactive chemistry under illumination. Those properties translate directly into biosensors that detect disease markers at vanishingly low concentrations, light-activated cancer therapies, wearable health monitors, and antimicrobial wound treatments. What makes MoS₂ stand apart from other nanomaterials is that its electronic behavior can be tuned by simply changing how many atomic layers thick it is, giving researchers a remarkable degree of control over its biological performance.

How Thickness Changes Everything

In its natural bulk crystal form, MoS₂ is an indirect bandgap semiconductor, meaning it absorbs and emits light inefficiently and produces almost no photoluminescence. When researchers thin that crystal down to a single layer of atoms, the material undergoes a dramatic transformation: it becomes a direct bandgap semiconductor, and strong photoluminescence suddenly appears.¹ The indirect bandgap in the bulk material sits below the direct gap, but as the number of layers decreases, that indirect gap shifts upward in energy by more than 0.6 electron volts until, at the single-layer limit, the direct gap takes over entirely.²

In practical terms, the bandgap of monolayer MoS₂ sits around 1.8 to 1.9 electron volts, while few-layer versions can range significantly lower. Measurements on crystals grown layer by layer have shown the bandgap shifting from roughly 2.4 eV at the thinnest films down to about 1.0 eV at five layers, illustrating just how sensitive the electronic structure is to thickness.³ For bioscience, this tunability is the entire point. A monolayer that glows brightly under excitation is useful for cellular imaging. A few-layer sheet that absorbs strongly in the near-infrared is useful for therapies that need to penetrate tissue. Researchers choose the thickness to match the job.

Why a Tunable Bandgap Matters for Biology

Biological tissues are mostly transparent to near-infrared light, which is why the medical world prizes materials that can absorb in that wavelength window. MoS₂ nanoflakes absorb strongly in the near-infrared region, and their photothermal conversion efficiency is high enough to heat targeted tissue when illuminated with a laser.⁴ At the same time, monolayer MoS₂ particles (quantum dots and nanodots) fluoresce brightly enough to serve as optical labels inside living cells, enabling researchers to track drug delivery or image specific molecules without conventional fluorescent dyes.

The bandgap also determines what happens when MoS₂ absorbs a photon and generates an excited electron. In certain configurations, that energy can be transferred to surrounding oxygen molecules, producing reactive oxygen species that are toxic to cancer cells and bacteria. The material therefore serves double duty: it can cook a tumor with heat and poison it with reactive chemistry at the same time. This dual capability, photothermal plus photodynamic, is a recurring theme in MoS₂ biomedical research and follows directly from the material’s electronic structure.

Detecting Disease Markers with MoS₂ Transistors

Some of the most striking bioscience results involve using MoS₂ as the channel in a field-effect transistor, the same type of device that powers computer chips, but repurposed to detect biological molecules. When a target molecule lands on the surface of the MoS₂ channel, it changes the local electrical environment and shifts the current flowing through the device. Because MoS₂ is atomically thin and has a bandgap well-suited to switching behavior, it responds to astonishingly small amounts of a target.

Early demonstrations showed that MoS₂ transistor biosensors could detect specific proteins at concentrations as low as 100 femtomolar, producing a sensitivity of 196 in terms of the device’s signal change.⁵ More recent designs have pushed even further. A biosensor built from rings of MoS₂ nanopores, inspired by the gatekeeper structures found in cell nuclei, achieved a detection limit of 1 attogram per milliliter for the stress hormone cortisol.⁶ An attogram is a billionth of a billionth of a gram. At that sensitivity, you could theoretically detect a target molecule in a sample where almost none exists.

These transistor-based sensors are “label-free,” meaning they do not require fluorescent tags or other chemical markers to detect the target. The MoS₂ channel does the sensing directly through electrical changes. That simplicity matters for practical applications: fewer preparation steps, faster results, and the potential for compact point-of-care devices.

Fluorescence Sensing Inside Living Cells

Monolayer MoS₂ nanodots emit light, and that emission can be switched on and off by molecules that interact with defect sites on the nanodot surface. Researchers have exploited this to build fluorescent sensors for glutathione, a small molecule that plays a critical role in cellular defense against oxidative stress. When the drug 6-mercaptopurine attaches to sulfur vacancy sites on MoS₂ nanodots, it quenches their fluorescence. Glutathione then displaces the drug, restoring the glow. The system works both as a sensor, detecting glutathione in red blood cells and live cells, and as a triggered drug-delivery vehicle that releases its payload in response to glutathione levels.⁷

This kind of responsive sensing is difficult to achieve with conventional fluorescent dyes. Most dyes simply glow when illuminated and do not change behavior based on the chemical environment. The bandgap-derived photoluminescence of MoS₂, combined with its surface chemistry, enables a feedback loop between sensing and function that could eventually allow nanoscale drug carriers to report whether they have released their cargo.

Light-Activated Cancer Therapy

Photothermal therapy uses a material that absorbs laser light and converts it to heat, raising the local temperature enough to kill cancer cells. MoS₂ nanoflakes are strong candidates because they absorb near-infrared light efficiently and convert it to heat at rates competitive with more established photothermal agents. When embedded in an injectable hydrogel, MoS₂ nanoflakes treated with bovine serum albumin showed both photothermal heating and reactive oxygen species production under 808 nm laser exposure, enabling a combined photothermal-photodynamic attack on breast cancer tumors in animal models.⁸

The reactive oxygen species side of this equation has been enhanced further by pairing MoS₂ with gold nanoparticles. The gold provides a plasmonic effect, concentrating the electromagnetic field at the material’s surface, which accelerates the generation of singlet oxygen. One such hybrid achieved a singlet oxygen quantum yield of about 0.22, substantially higher than previously reported hybrid photosensitizers.⁹ That same gold-MoS₂ hybrid was effective against bacterial pathogens, a reminder that the line between cancer therapy and infection control is thin when the mechanism is reactive oxygen species.

Killing Bacteria with Light and Nanostructure

Antibiotic resistance has pushed researchers to look for physical and photochemical methods of killing bacteria, and MoS₂ fits neatly into that search. Its adjustable bandgap, high near-infrared absorption, and large surface area make it well-suited for light-activated antibacterial work.¹⁰ When a near-infrared laser hits MoS₂-based nanostructures, the heat generated and the reactive oxygen species produced can disrupt bacterial membranes, cause protein leakage, and shut down the energy-producing machinery of the cell.¹¹

The numbers are impressive. An octahedral MoS₂-MoN nanosystem activated by a 980 nm laser achieved antibacterial efficiencies above 94% against E. coli and above 97% against S. aureus within five minutes, combining photothermal heating with physical membrane disruption from the particles’ sharp edges.¹² Because this approach relies on heat and physical damage rather than chemical antibiotics, bacteria cannot easily develop resistance to it through the usual genetic mutations. That gives MoS₂-based antibacterial materials a potential long-term advantage over conventional antimicrobial agents.

Healing Chronic Wounds

Diabetic wounds heal slowly because of persistent infection, oxidative stress, and poor blood vessel formation. MoS₂ nanosheets have been incorporated into 3D-bioprinted hydrogel scaffolds designed to address all three problems simultaneously. The MoS₂ component speeds up the gelling of the hydrogel, provides antioxidant activity to counteract oxidative stress, and enables photothermal sterilization of the wound bed. In animal models of infected diabetic wounds, these scaffolds promoted wound closure, reduced bacterial infection, and relieved oxidative damage.¹³

Separately, injectable hydrogels containing chitosan-stabilized MoS₂ nanosheets have demonstrated the ability to eradicate bacteria in infected wounds while accelerating blood vessel growth, a crucial step in wound repair.¹⁴ The common thread across these wound-healing studies is that MoS₂ is not just a passive structural component. Its bandgap-dependent light absorption and surface chemistry actively participate in the healing process.

Catalytic Biosensing Without Enzymes

Natural enzymes like peroxidase catalyze reactions that clinical labs use to detect neurotransmitters and other biomarkers. But enzymes are expensive, fragile, and require careful storage. MoS₂-based nanocomposites can mimic these enzymatic functions. When Prussian blue nanoparticles are loaded onto MoS₂ nanosheets, the resulting material acts as a peroxidase-like nanozyme, catalyzing a color-change reaction in the presence of hydrogen peroxide that can be used to detect dopamine without any biological enzyme involved.¹⁵

The appeal of nanozymes extends beyond dopamine. MoS₂’s layered structure provides abundant electroactive edge sites and versatile surface chemistry, making it a flexible scaffold for detecting various cancer biomarkers through electrochemical methods.¹⁶ Because nanozymes are stable at temperatures and pH levels that would destroy natural enzymes, they could enable diagnostic testing in settings without refrigeration or laboratory infrastructure, a meaningful advance for point-of-care medicine in resource-limited areas.

Wearable Health Monitors

The same sensitivity that makes MoS₂ transistors useful for lab-based detection is being adapted for wearable devices. Sweat contains glucose, electrolytes, and other metabolites that reflect what is happening inside the body, and MoS₂-based sensors can detect these markers noninvasively. A smartwatch prototype incorporating a transistor biosensor with a channel made of MoS₂, MXene, and silver nanowires achieved a detection limit of 0.001 micromolar for glucose in sweat, with high sensitivity and minimal interference from other sweat components.¹⁷

Beyond glucose, flexible MoS₂-polyaniline sensors have been tested for real-time pH monitoring in sweat. Sweat pH correlates with hydration status and metabolic states, and a skin-attachable sensor that tracks it continuously could be valuable for athletes and patients with chronic conditions alike.¹⁸ These wearable applications rely on the fact that MoS₂ retains its semiconducting properties even when deposited on flexible substrates, a consequence of its atomically thin structure. Bend it, stretch it, and the bandgap-dependent electrical response persists.

Making MoS₂ Play Well with the Body

Raw nanomaterials introduced into a biological environment face immediate challenges: proteins stick to them, immune cells try to engulf them, and they tend to clump together. Surface functionalization solves these problems. The most common approach is coating MoS₂ with polyethylene glycol (PEG), a polymer widely used in pharmaceuticals. PEGylated MoS₂ quantum dots show strong photoluminescence, low toxicity to cells, and excellent stability in physiological fluids.¹⁹

More complex functionalization is also possible. Iron oxide nanoparticles can be self-assembled onto MoS₂ nanosheets through sulfur chemistry, then coated with two types of PEG, creating a multimodal platform that combines photothermal therapy with magnetic resonance imaging and other imaging techniques.²⁰ The sulfur atoms on the MoS₂ surface provide natural anchoring points for metals and molecules, which is a significant practical advantage: you can build up complex nanostructures without harsh chemical coupling agents.

Biocompatibility and What Happens After

A material can perform brilliantly in the lab and still fail in the body if it is toxic or accumulates in organs. The safety picture for MoS₂ is encouraging but not yet complete. In mouse studies, PEGylated MoS₂ nanosheets were degraded and excreted almost completely within one month, a marked advantage over related materials like tungsten disulfide and titanium disulfide, which lingered in organs for months.²¹ The degradation pathway involves MoS₂ breaking down into molybdate ions, which are then cleared through the kidneys.²²

The caveat is that dose matters. Studies in mice using pristine (uncoated) MoS₂ nanosheets found no significant toxicity at concentrations below about 1.0 mg per kilogram of body weight. Above that threshold, at 1.5 mg per kilogram, the animals showed changes in blood markers, liver enzymes, and tissue structure.²³ Surface coatings like PEG substantially improve the safety profile, but the concern about incomplete degradation leading to accumulation in vital organs has not been fully resolved for long-term or repeated exposures. Most published toxicity studies have tracked animals for weeks to a few months, and the field still lacks comprehensive data on what happens over years of exposure in larger animals.

Hybrid Nanostructures and Heterostructures

MoS₂ rarely works alone in cutting-edge bioscience applications. Researchers frequently combine it with other materials to get capabilities that neither material offers by itself. Graphene-MoS₂ heterostructures, for example, have been used to build biosensors based on an optical phenomenon called the photonic spin Hall effect. The heterostructure amplifies changes in the refractive index of the sensing medium when biomolecules bind to the surface, enabling highly sensitive detection without any electrical measurement at all.²⁴

Other hybrids pair MoS₂ with gold nanoparticles for enhanced reactive oxygen generation, with iron oxide for magnetic imaging, or with conducting polymers for flexible electronics. In each case, MoS₂ contributes its bandgap-derived optical and electronic properties while the partner material fills in a capability gap. The layered structure of MoS₂ makes these combinations physically straightforward: its flat, high-surface-area sheets provide a natural platform for depositing or growing other nanomaterials on top.

Phase Engineering and Doping

MoS₂ exists in more than one crystal phase. The semiconducting 2H phase, with its bandgap, is the one most relevant to biosensing and light-based therapies. But the metallic 1T phase, which has no bandgap and conducts electricity freely, has its own uses, particularly in electrochemical sensing where high conductivity at the electrode surface matters more than semiconducting behavior. Researchers can switch between these phases through chemical treatment, and some biosensor designs deliberately use mixed-phase MoS₂ to combine the advantages of both.²⁵

Doping, the intentional introduction of foreign atoms into the crystal lattice, offers another lever for tuning performance. Adding nitrogen, for instance, can shift the bandgap and alter how MoS₂ interacts with biological molecules at its surface. Surface modifications, whether chemical grafts or adsorbed molecules, can similarly adjust electronic behavior without changing the crystal structure. The practical result is that a single base material, MoS₂, can be customized across a wide spectrum of electronic and chemical properties to match specific biomedical needs. Few other nanomaterials offer that degree of engineerability.

Where the Gaps Remain

For all the promising lab results, MoS₂ has not yet entered routine clinical use. Scaling up production of high-quality, uniform monolayer or few-layer MoS₂ remains a manufacturing challenge. The material’s properties depend sensitively on thickness, defect density, and edge structure, and batch-to-batch variability can be significant. Regulatory pathways for nanomaterial-based medical devices and therapeutics are still being established, and the long-term toxicity data needed for regulatory approval are incomplete. The kidney clearance pathway for degraded MoS₂ is reassuring, but the possibility of accumulation from incomplete degradation in organs remains an open question that needs longer and larger animal studies before human trials become realistic.²² The wearable sensing applications may reach consumers sooner, since skin-contact devices avoid the internal toxicity question entirely, but even there the challenge of reliable, reproducible manufacturing at scale has not been fully solved.